Rolfe Lindsey 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Feb 26, 2025
Insider Transaction Report
Form 4
Rolfe Lindsey
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-24+127,500→ 255,000 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (127,500 underlying)
Footnotes (1)
- [F1]On October 1, 2024, the Reporting Person was granted an option to purchase 255,000 shares of Common Stock, which vest in two equal installments subject to the satisfaction of certain performance criteria. On February 24, 2025, the Issuer's Board of Directors confirmed that the performance criteria had been met with regards to the second installment, resulting in the vesting of 127,500 shares.